Breast ductal carcinoma in situ

Breast cancer ductal carcinoma in situ is the proliferation of epithelial cells in the breast lumen. It is a non-invasive form of breast cancer that may progress to breast cancer in about 25-60% of untreated cases (Wang J et al. (2024)). Progression is based off of several factors including genetics, hormone receptor status, and growth receptor status. It is typically detected in mammography screening programs and over 50% of cases do not progress to invasive breast cancer. Treatment usually consists of surgery, although radiotherapy and hormonal treatment are options as well (Tomlinson-Hansen SE et al. (2024)).

Differential abundance and machine learning analysis

This section presents the disease-specific results of the differential abundance and machine learning analyses. The analyses are reported for three comparisons: 1) disease vs. all other diseases, 2) disease vs. diseases from the same class, and 3) disease vs. healthy samples.

Disease vs All other
Disease vs Class
Disease vs Healthy